Prevalence of sarcopenia among people living with HIV defined by the revised European working group on sarcopenia in older people
Authors:
- 21 July 2024
- journal article
- research article
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 35 (11) , 902-909
Abstract
Background: Sarcopenia is a progressive and systemic skeletal muscle disorder associated with an increased risk of hospitalization and adverse effects on survival. This study aims to investigate the prevalence and related risk factors of sarcopenia in people living with HIV using the revised European Working Group on Sarcopenia in Older People (EWGSOP2) definition. Methods: This cross-sectional study comprising 379 patients with confirmed HIV infection evaluated the appendicular skeletal muscle mass by employing the bioelectrical impedance analysis method. Muscle strength and functional mobility were analyzed using the five-time sit-to-stand test and the timed “Up and Go” test. Results: The prevalence rates of pre-sarcopenia and sarcopenia among people living with HIV were 3.4 % and 2.1 % according to the revised EWGSOP2 definition. Advanced age (Odds Ratio 1.07, p = .03), lower body mass index (Odds Ratio 0.79, p = .012) and CD4+ T-cell count below 500/μl (Odds Ratio 2.22, p = .007) were identified as significant factors associated with sarcopenia. Sarcopenia was also identified as a significant correlate of frailty ( p < .001). Conclusion: This is the first study examining the prevalence of sarcopenia in people living with HIV according to the revised EWGSOP2 clinical algorithm. Advanced age, lower body mass index and a poor immune status are determined as promoting factors of sarcopenia. Sarcopenia significantly correlates with frailty. Standardized clinical algorithms are essential for reliable sarcopenia diagnosis in people living with HIV in order to promote intervention strategies and to prevent adverse health outcomes.Keywords
This publication has 34 references indexed in Scilit:
- Sarcopenic Obesity Phenotypes in Patients With HIV: Implications for Cardiovascular Prevention and RehabilitationCanadian Journal of Cardiology, 2023
- Role of sarcopenia in the frailty transitions in older adults: a population‐based cohort studyJournal of Cachexia, Sarcopenia and Muscle, 2022
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic reviewAging Clinical and Experimental Research, 2021
- Predictors of sarcopenia in young hospitalized patients living with HIVThe Brazilian Journal of Infectious Diseases, 2021
- Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating?Journal of Cachexia, Sarcopenia and Muscle, 2017
- Sarcopenia as the Biological Substrate of Physical FrailtyClinics in Geriatric Medicine, 2015
- Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adultsClinical Nutrition, 2015
- SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomesJournal of Cachexia, Sarcopenia and Muscle, 2015
- From sarcopenia to frailty: a road less traveledJournal of Cachexia, Sarcopenia and Muscle, 2014